Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Johnson & Johnson (JNJ), And Why The Procter & Gamble Company (PG) Is A Buy

Page 1 of 2

The Procter & Gamble Company (NYSE:PG)Blue chip stocks are great companies to add to your portfolio. They have a long history of strong growth and have strong, reputable brands. The Procter & Gamble Company (NYSE:PG) is one blue chip you should consider for your portfolio for three key reasons.

Economic health

The Procter & Gamble Company (NYSE:PG)’s stock price has risen 17% so far this year. This is a great return on the stock for a company that has had a slight decline in net income over the last few years. The earnings decline is due to an increase in overall expenses.

Despite the increase in expenses, the company still has a strong gross margin of 49% and operating margin of 17%. Its return on equity is over 17%, as well.

Johnson & Johnson (NYSE:JNJ), one of its rivals, has higher margins with a gross margin of 67% and operating margin of 18.94%. The company has witnessed a dip in earnings over the last few years, but in 2011 and 2012, net income rose steadily.

The outlook for Johnson & Johnson (NYSE:JNJ) is very strong. Analysts expect top line growth of 5%-6%, reaching $70 billion in 2013. Earnings are expected to grow at a slightly higher rate in the next year. Because Johnson & Johnson (NYSE:JNJ) provides more than just consumer products, it will benefit from the increased need of new pharmaceuticals to combat cancer, HIV, and other chronic diseases.

Investor sentiment

Institutional investors have been increasing their positions in P&G. This is a great sign for investors as they are selecting a new stock or confirming a current position. In the first quarter of this year, Fidelity Contrafund initiated a position in P&G. In addition to this new position, two other funds have increased their positions.

The Fidelity Balanced Fund increased its P&G position by 2%. Fidelity’s Magellan Fund increased its position by almost 50%.

Eight Wall street analysts have a buy rating on P&G and 13 have a hold rating.

These are all strong signs for investors. New funds are purchasing this stock, current funds are increasing their positions, and analysts are telling people to pay attention to The Procter & Gamble Company (NYSE:PG).

Customer growth

One customer makes up 17% of all of P&G’s revenue. Having such concentrated revenue is sometimes a risk for a company. However, in this case, it looks like a good thing. This one customer is Wal-Mart Stores, Inc. (NYSE:WMT).

Wal-Mart Stores, Inc. (NYSE:WMT) has witnessed strong growth in the last few years. In the last five years, the company’s net income has grown an impressive 27%. It has plenty of plans to continue this growth in the future.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!